Pfizer, Nvidia Support AI Drug Discovery Company Discover how CytoReason, backed by Pfizer and Nvidia, is using AI to accelerate drug discovery and model human diseases for faster, safer treatments. Massive Investment Fuels AI-Powered Innovation CytoReason, an AI-driven company, recently secured an $80 million funding round. This investment will help bring its…
New Microservices from NVIDIA Strengthen Sovereign AI NVIDIA microservices empower sovereign AI with regional language models Nations worldwide are increasingly adopting sovereign AI policies. These policies focus on building AI systems using local infrastructure, data, and expertise. The goal is to ensure AI respects local laws, values, and cultural norms. To…
Netris Announces Software to Aid in the Development
AWS CEO Matt Garman believes AI coding tools could spell the end of the developer profession as we know it.
With its sales of AI hardware, Nvidia ought to be printing money right now. Rather, Its Stock Is Declining
Nvidia Stock Drops as Earnings Indicate AI
Isn’t Increasing Sales as Expected
